Format

Send to

Choose Destination
Curr Allergy Asthma Rep. 2015 May;15(5):20. doi: 10.1007/s11882-015-0521-5.

Severe asthma in school-age children: evaluation and phenotypic advances.

Author information

1
Department of Pediatrics, Washington University, St. Louis, MO, USA.

Abstract

Although the majority of children with asthma have a favorable clinical response to treatment with low to moderate doses of inhaled corticosteroids (ICS), a small subset of children have "severe" asthma characterized by ongoing symptoms and airway inflammation despite treatment with high doses of ICS and even oral corticosteroids. Although there is symptom heterogeneity in the affected children, children with severe asthma share the risk for adverse outcomes, including recurrent and potentially life-threatening exacerbations, which contribute to substantial economic burden. This article reviews current knowledge of severe asthma in school-age children (age 6-17 years) with a focus on recent literature published after January 2012. Clinical management approaches for children with severe asthma are discussed as well as current phenotyping efforts and emerging phenotypic-directed therapies that may be of benefit for subpopulations of children with severe asthma in the future.

PMID:
26134431
DOI:
10.1007/s11882-015-0521-5
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center